Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vismodegib
vismodegib
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
Hungry biotechs make better partners for Big Pharma
Fierce Biotech
Thu, 12/8/11 - 11:58 am
biotech
Big Pharma
Roche
Zelboraf
vismodegib
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha
Thu, 11/10/11 - 01:08 pm
Curis
milestone payments
FDA
basal cell carcinoma
Genentech
vismodegib
FDA gives priority to Roche skin cancer drug vismodegib
Pharma Times, UK
Wed, 11/9/11 - 12:07 pm
Roche
vismodegib
FDA
skin cancer
basal cell carcinoma
hedgehog pathway inhibitor
Roche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study
Bloomberg
Sat, 09/24/11 - 12:43 pm
vismodegib
Roche
basal cell carcinoma
skin cancer
Roche Seeks FDA Approval for Skin Cancer Drug
Bloomberg
Mon, 09/12/11 - 09:58 am
FDA
Roche
skin cancer
vismodegib
Roche preps vismodegib app after Ph2 skin cancer success
Fierce Biotech
Mon, 06/20/11 - 11:57 am
Roche
skin cancer
vismodegib
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
Roche, Curis Drug Prevented Lesions, Reduced Tumor Size in Trial
Bloomberg
Fri, 04/1/11 - 11:32 am
Roche
Curis
skin cancer
vismodegib
Let's See Some Data, Curis
Motley Fool
Tue, 03/22/11 - 09:26 am
Curis
vismodegib
skin cancer